Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 30, 2019
Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary centerC Christofer Juhlin, Inga-Lena Nilsson, Kristina Lagerstedt-Robinson, et al.
European Journal of Endocrinology|March 4, 2023
Immunohistochemical characterization of a steroid-secreting oncocytic adrenal carcinoma responsible for paraneoplastic hyperparathyroidismMagalie Haissaguerre, Estelle Louiset, Christofer C Juhlin, et al.
Thyroid Research|August 14, 2021
Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation - association or random chance?Klara Johansson, Adam Stenman, Johan O Paulsson, et al.
Surgery|October 12, 2015
DNA copy amplification and overexpression of SLC12A7 in adrenocortical carcinomaTaylor C Brown, C Christofer Juhlin, James M Healy, et al.
Thyroid Research|October 2, 2025
CD44v6 expression in non-anaplastic thyroid carcinoma: characterization of candidates for targeted therapyAdam Stenman, Joachim N Nilsson, Vincenzo Condello, et al.
Plos One|September 7, 2016
Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical CarcinomasPaola Nolé, Britt Duijndam, Adam Stenman, et al.
The American Journal of Surgical Pathology|November 20, 2018
Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant BehaviorAdam Stenman, Fredrika Svahn, Mohammad Hojjat-Farsangi, et al.
Genes, Chromosomes & Cancer|January 17, 2016
HRAS mutation prevalence and associated expression patterns in pheochromocytomaAdam Stenman, Jenny Welander, Ida Gustavsson, et al.
Brain Pathology (Zurich, Switzerland)|August 18, 2020
TERT promoter mutations in primary and secondary WHO grade III meningiomaAndrea Daniela Maier, Adam Stenman, Fredrika Svahn, et al.
Cancers|September 29, 2019
Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic DiseaseMartin Hysek, Johan O Paulsson, Kenbugul Jatta, et al.
Pageof 6